JCI Insight Issues Research Articles in July 8, 2024 Edition
July 09, 2024
July 09, 2024
ANN ARBOR, Michigan, July 9 -- JCI Insight, a peer-reviewed journal from the American Society for Clinical Investigation that says it features preclinical and clinical research studies, published research articles on the following topics in its July 8, 2024, edition (Vol. 9, Issue 13):
* Drug screening in human physiologic medium identifies uric acid as an inhibitor of rigosertib efficacy
* Protein biomarker signature in patients with spinal and bulbar muscular atrophy< . . .
* Drug screening in human physiologic medium identifies uric acid as an inhibitor of rigosertib efficacy
* Protein biomarker signature in patients with spinal and bulbar muscular atrophy< . . .